Blood erythritol falling during weight loss went with slightly better heart risk scores, in 664 adults

Erythritol had a good run. It tastes like sugar, has almost no calories, does not spike blood sugar, and became the base of countless sugar-free and keto products. Then research linked high blood levels of it to heart attacks and strokes, and a sweetener marketed as the healthy choice acquired a question mark.

A new analysis in the American Journal of Clinical Nutrition adds a piece to the puzzle. In a two-year weight-loss trial, adults whose blood erythritol fell also saw their estimated heart risk improve, by a small amount.

What erythritol is and why it is under suspicion

Erythritol is a sugar alcohol, a class of low-calorie sweeteners. MedlinePlus explains the appeal of sugar substitutes generally: they provide sweetness to foods and drinks without adding a lot of extra calories, and most “sugar-free” or low-calorie food products you buy at the store are made using sugar substitutes.

The worry comes from blood studies. The authors summarize it in their opening line: high circulating levels of sugar alcohols have recently been linked to increased risks of cardiovascular events. What was missing was evidence about change: if levels come down, does risk come down with them?

How the erythritol study used a diet trial

The researchers went back to a large weight-loss trial called POUNDS Lost, in which adults with overweight or obesity followed one of several diets for two years. Erythritol and two related sugar alcohols were measured in stored blood samples at the start, from about 800 people, and again at six months.

Heart risk was not measured by waiting for heart attacks. The primary outcome was the 10-year risk estimated using the validated pooled cohort equations, a standard calculator doctors use to estimate a person’s chance of heart attack or stroke from their age, blood pressure, cholesterol and other factors.

What happened as erythritol fell

At the start, more erythritol went with more risk. Higher baseline levels of erythritol were associated with higher estimated risk, and the same was true of the other sugar alcohols measured.

Change is where erythritol stood out. Greater decreases in erythritol, but not the other polyols, were significantly associated with reductions of risk estimates at 6 months. The early drop also looked forward: initial declines in plasma erythritol were associated with long-term improvements in estimated risk at two years, along with falls in a particularly harmful subset of LDL and VLDL cholesterol particles.

How much the heart risk scores moved

The associations were consistent, but they were not large. Each step of decline in erythritol went with an improvement of a fraction of a percentage point in estimated 10-year risk. For an individual, that is barely noticeable.

The reason the result matters is its direction. Previously, the evidence showed only that people with high levels had more heart trouble, which could mean many things. Showing that falling levels travel with improving risk, in the same people, over time, is a step beyond that. It fits the idea that erythritol, or whatever raises it, is part of the picture rather than an innocent bystander, though it stops well short of proving that the sweetener itself does harm.

What blood erythritol cannot tell us

The biggest gap is that the measure was erythritol in the blood, not erythritol eaten. That means the analysis cannot say whether levels fell because people ate fewer sugar-free products or because weight loss and dieting changed how the body handled it. Blood levels and intake are not the same thing.

This is also an observational analysis inside a trial, not a trial of erythritol itself. People who lost more weight may have had falling erythritol and improving risk for the same underlying reason, and the analysis cannot fully separate the two. Risk scores are estimates, not heart attacks.

What this means for erythritol in sugar-free foods

It is not a verdict on the sweetener. Nothing here tested cutting erythritol out of anyone’s diet, and the effect sizes are small. Anyone wanting to act on the broader concern can reasonably cut back on heavily sweetened products, whatever they are sweetened with, which is sensible advice on other grounds too.

What the study does is keep erythritol on the list of things worth testing directly. The question that would settle it, a trial that changes erythritol intake and measures what happens to the heart, has not yet been answered.